117 related articles for article (PubMed ID: 35034828)
21. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
22. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
[TBL] [Abstract][Full Text] [Related]
23. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM
Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796
[TBL] [Abstract][Full Text] [Related]
24. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.
Park KJ; Bramlage MP; Ellenson LH; Pirog EC
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):8-11. PubMed ID: 18776815
[TBL] [Abstract][Full Text] [Related]
25. Endocervical glandular lesions: a diagnostic approach combining a semi-quantitative scoring method to the expression of CEA, MIB-1 and p16.
Pavlakis K; Messini I; Athanassiadou S; Kyrodimou E; Pandazopoulou A; Vrekoussis T; Stathopoulos EN
Gynecol Oncol; 2006 Dec; 103(3):971-6. PubMed ID: 16876235
[TBL] [Abstract][Full Text] [Related]
26. [A bilateral epithelial myoepithelial carcinoma of the parotid gland].
Tauziède-Espariat A; Raffoul J; Sun SR; Monnin C; Lassabe C; Costes V
Ann Pathol; 2015 Dec; 35(6):489-95. PubMed ID: 26586087
[TBL] [Abstract][Full Text] [Related]
27. Diffuse laminar endocervical glandular hyperplasia: a case report.
Dainty LA; Krivak TC; Webb JC; Zahn CM; Elkas JC; Chernofsky MR; Rose GS; Maxwell GL
Int J Gynecol Cancer; 2009 Aug; 19(6):1091-3. PubMed ID: 19820374
[TBL] [Abstract][Full Text] [Related]
28. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype.
Mikami Y; Hata S; Melamed J; Fujiwara K; Manabe T
Histopathology; 2001 Oct; 39(4):364-72. PubMed ID: 11683936
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
[TBL] [Abstract][Full Text] [Related]
30. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
31. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma.
Tot T
Eur J Cancer; 2002 Apr; 38(6):758-63. PubMed ID: 11937308
[TBL] [Abstract][Full Text] [Related]
32. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
33. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
34. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
[TBL] [Abstract][Full Text] [Related]
35. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
36. [A case of urothelial carcinoma with trophoblastic differentiation and review of the literature].
Cazorla A; Sibony M; Pedron P; Munz-Beaugrand C
Ann Pathol; 2016 Oct; 36(5):347-350. PubMed ID: 27639773
[TBL] [Abstract][Full Text] [Related]
37. Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant lesions of these organs.
Suzuki M; Usui N; Furugen Y; Mitsuhasi N
Int J Clin Oncol; 2001 Feb; 6(1):19-24. PubMed ID: 11706522
[TBL] [Abstract][Full Text] [Related]
38. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix.
Kojima A; Mikami Y; Sudo T; Yamaguchi S; Kusanagi Y; Ito M; Nishimura R
Am J Surg Pathol; 2007 May; 31(5):664-72. PubMed ID: 17460448
[TBL] [Abstract][Full Text] [Related]
39. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
40. Mucinous epithelial lesions in endometrial curettage material: a diagnostic challenge.
Pavlakis K; Vrekoussis T; Messini I; Voulgaris Z; Chrysanthakis D; Yiannou P; Stofas A; Panoskaltsis T
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):607-13. PubMed ID: 22531687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
